<html xmlns:v="urn:schemas-microsoft-com:vml" xmlns:o="urn:schemas-microsoft-com:office:office" xmlns:w="urn:schemas-microsoft-com:office:word" xmlns:m="http://schemas.microsoft.com/office/2004/12/omml" xmlns="http://www.w3.org/TR/REC-html40">
<head>
<meta http-equiv="Content-Type" content="text/html; charset=us-ascii">
<meta name="Generator" content="Microsoft Word 15 (filtered medium)">
<!--[if !mso]><style>v\:* {behavior:url(#default#VML);}
o\:* {behavior:url(#default#VML);}
w\:* {behavior:url(#default#VML);}
.shape {behavior:url(#default#VML);}
</style><![endif]--><style><!--
/* Font Definitions */
@font-face
{font-family:"Cambria Math";
panose-1:2 4 5 3 5 4 6 3 2 4;}
@font-face
{font-family:Calibri;
panose-1:2 15 5 2 2 2 4 3 2 4;}
/* Style Definitions */
p.MsoNormal, li.MsoNormal, div.MsoNormal
{margin:0in;
margin-bottom:.0001pt;
font-size:11.0pt;
font-family:"Calibri",sans-serif;}
a:link, span.MsoHyperlink
{mso-style-priority:99;
color:#0563C1;
text-decoration:underline;}
a:visited, span.MsoHyperlinkFollowed
{mso-style-priority:99;
color:#954F72;
text-decoration:underline;}
p.msonormal0, li.msonormal0, div.msonormal0
{mso-style-name:msonormal;
mso-margin-top-alt:auto;
margin-right:0in;
mso-margin-bottom-alt:auto;
margin-left:0in;
font-size:12.0pt;
font-family:"Times New Roman",serif;}
span.EmailStyle18
{mso-style-type:personal;
font-family:"Arial",sans-serif;
color:windowtext;}
span.EmailStyle19
{mso-style-type:personal-reply;
font-family:"Arial",sans-serif;
color:#1F497D;}
.MsoChpDefault
{mso-style-type:export-only;
font-size:10.0pt;}
@page WordSection1
{size:8.5in 11.0in;
margin:1.0in 1.0in 1.0in 1.0in;}
div.WordSection1
{page:WordSection1;}
--></style><!--[if gte mso 9]><xml>
<o:shapedefaults v:ext="edit" spidmax="1026" />
</xml><![endif]--><!--[if gte mso 9]><xml>
<o:shapelayout v:ext="edit">
<o:idmap v:ext="edit" data="1" />
</o:shapelayout></xml><![endif]-->
</head>
<body lang="EN-US" link="#0563C1" vlink="#954F72">
<div class="WordSection1">
<p class="MsoNormal"><span style="font-size:10.0pt;font-family:"Arial",sans-serif;color:#1F497D">Hello CAFR Contacts,<o:p></o:p></span></p>
<p class="MsoNormal"><span style="font-size:10.0pt;font-family:"Arial",sans-serif;color:#1F497D"><o:p> </o:p></span></p>
<p class="MsoNormal"><span style="font-size:10.0pt;font-family:"Arial",sans-serif;color:#1F497D">It does not appear that we have any expenditures yet under CFDA 93.461, as it’s not on the D40 profile in SFMA, but in case there are some to come in FY 2021, the
information below may be of value for your agencies, especially those involved with hospitals and health departments.
<o:p></o:p></span></p>
<p class="MsoNormal"><span style="font-size:10.0pt;font-family:"Arial",sans-serif;color:#1F497D"><o:p> </o:p></span></p>
<p class="MsoNormal"><span style="font-size:10.0pt;font-family:"Arial",sans-serif;color:#1F497D">Rob<o:p></o:p></span></p>
<p class="MsoNormal"><span style="font-size:10.0pt;font-family:"Arial",sans-serif;color:#1F497D"><o:p> </o:p></span></p>
<div>
<div style="border:none;border-top:solid #E1E1E1 1.0pt;padding:3.0pt 0in 0in 0in">
<p class="MsoNormal"><b>From:</b> Poynter, R. Kinney <kpoynter@nasact.org> <br>
<b>Sent:</b> Thursday, February 11, 2021 9:56 AM<br>
<b>To:</b> NSAAAuditors <NSAAAuditors@nasact.org>; NASCComptrollers <NASCComptrollers@nasact.org>; StateTreasurers <StateTreasurers@nasact.org>; NSAA2021SingleAuditCommittee <NSAA2021SingleAuditCommittee@nasact.org>; NASCCAFR <NASCCAFR@nasact.org>; UniformGuidanceImplementationWorkgroup
<UniformGuidanceImplementatinWorkgroup@nasact.org><br>
<b>Cc:</b> NSAAAuditorsCCs <NSAAAuditorsCCs@nasact.org>; NASCComptrollersCCs <NASCComptrollersCCs@nasact.org>; StateTreasurersCCs <StateTreasurersCCs@nasact.org>; Rowland, Sherri <srowland@nasact.org>; Chebinou, Cornelia <cchebinou@nasact.org>; Strudgeon, George
<george.strudgeon@apa.virginia.gov><br>
<b>Subject:</b> CFDA 93.461 COVID-19 Testing for the Uninsured<br>
<b>Importance:</b> High<o:p></o:p></p>
</div>
</div>
<p class="MsoNormal"><o:p> </o:p></p>
<p class="MsoNormal"><span style="font-size:10.0pt;font-family:"Arial",sans-serif">NASACT Members –<o:p></o:p></span></p>
<p class="MsoNormal"><span style="font-size:10.0pt;font-family:"Arial",sans-serif"><o:p> </o:p></span></p>
<p class="MsoNormal"><span style="font-size:10.0pt;font-family:"Arial",sans-serif">George Strudgeon, Audit Director – Compliance Assurance, Virginia Auditor of Public Accounts, brought the following issue relating to CFDA 93.461 (<i>COVID-19 Testing for the
Uninsured</i>) to our attention. This could potentially impact both auditees and auditors, specifically those that have medical providers (e.g. university and state hospitals, health departments, etc.) included within the financial statements they compile
or audit, respectively. <o:p></o:p></span></p>
<p class="MsoNormal"><span style="font-size:10.0pt;font-family:"Arial",sans-serif"><o:p> </o:p></span></p>
<p class="MsoNormal"><span style="font-size:10.0pt;font-family:"Arial",sans-serif">Many thanks to George for bringing this issue to our attention.<o:p></o:p></span></p>
<p class="MsoNormal"><span style="font-size:10.0pt;font-family:"Arial",sans-serif"><o:p> </o:p></span></p>
<p class="MsoNormal"><span style="font-size:10.0pt;font-family:"Arial",sans-serif">Thank you,
<o:p></o:p></span></p>
<p class="MsoNormal"><span style="font-size:10.0pt;font-family:"Arial",sans-serif"><o:p> </o:p></span></p>
<div>
<p class="MsoNormal"><span style="font-size:10.0pt;font-family:"Arial",sans-serif">R. Kinney Poynter, CPA<o:p></o:p></span></p>
<p class="MsoNormal"><span style="font-size:10.0pt;font-family:"Arial",sans-serif">NASACT Executive Director<o:p></o:p></span></p>
<p class="MsoNormal"><span style="font-size:10.0pt;font-family:"Arial",sans-serif">(859) 276-1147<o:p></o:p></span></p>
</div>
<div style="border:none;border-bottom:solid windowtext 1.5pt;padding:0in 0in 1.0pt 0in">
<p class="MsoNormal"><b><o:p> </o:p></b></p>
</div>
<p class="MsoNormal"><span style="font-size:10.0pt;font-family:"Arial",sans-serif"><o:p> </o:p></span></p>
<p class="MsoNormal"><b>Background:<o:p></o:p></b></p>
<p class="MsoNormal"><b>CFDA 93.461</b> which goes by the name “<b>COVID-19 Testing for the Uninsured</b>” within the
<a href="https://www.aicpa.org/content/dam/aicpa/interestareas/governmentalauditquality/resources/singleaudit/uniformguidanceforfederalrewards/downloadabledocuments/2020-omb-comp-supp/hhs-2020-compliance-supplement-addendum-final.pdf">
2020 Compliance Supplement Addendum</a> but now beta.sam.gov is reporting its name as “<b>COVID-19 Claims Reimbursement to Health Care Providers and Facilities for Testing, Treatment, and Vaccine Administration for the Uninsured</b>.” The change in name is
not the issue; however, it does appear to indicate that the scope of this program has expanded and will have a bigger impact for 2021. As for 2020, here is the issue along with a request for information that could help your membership.<o:p></o:p></p>
<p class="MsoNormal"><o:p> </o:p></p>
<p class="MsoNormal"><b>Issue:<o:p></o:p></b></p>
<p class="MsoNormal">Federal documents describe the program as if it operates as a claims reimbursement program similar to Medicaid and Medicare. As a result, some medical providers may have not reported the funding for CFDA 93.461 within the SEFA similar
to how they do not report funding for Medicaid and Medicare related to claims. See Example 1 Guidance below for an example of guidance that may cause a provider to believe that, same as Medicaid and Medicare claim reimbursement, that this program may not
be reported on the SEFA. However, as seen in Example 2 Guidance below, HRSA states that CFDA 93.461 must be included in the Single Audit. The Example 2 Guidance is consistent with information currently at
<a href="https://beta.sam.gov/fal/f042fd7ea46a49709f7e52618a2fd339/view?keywords=93.461&sort=-relevance&index=&is_active=true&page=1">
beta.sam.gov for this program</a>.<o:p></o:p></p>
<p class="MsoNormal"><o:p> </o:p></p>
<p class="MsoNormal"><b>What would be Helpful to the States:<o:p></o:p></b></p>
<p class="MsoNormal">We did some searching of the internet to determine if HRSA has publicly reported its payees for entities that received funding under CFDA 93.461; however, we were unable to locate this type of listing. We believe that this type of listing
would be helpful for us an other states to ensure SEFAs are complete. I have copied Tammie on this email because she is aware of this issue and may know of a listing that discloses the entities that received funding under CFDA 93.461 for state fiscal year
2020 and/or other guidance that may help the states.<o:p></o:p></p>
<p class="MsoNormal"><o:p> </o:p></p>
<p class="MsoNormal"><b><u>Example 1 Guidance:<o:p></o:p></u></b></p>
<p class="MsoNormal"><img border="0" width="708" height="168" style="width:7.375in;height:1.75in" id="Picture_x0020_1" src="cid:image003.jpg@01D7005E.F4C8B8C0" alt="cid:image005.jpg@01D70075.387FEB40"><o:p></o:p></p>
<p class="MsoNormal">Source: <a href="https://www.hrsa.gov/coviduninsuredclaim/frequently-asked-questions">
https://www.hrsa.gov/coviduninsuredclaim/frequently-asked-questions</a><o:p></o:p></p>
<p class="MsoNormal"><o:p> </o:p></p>
<p class="MsoNormal"><o:p> </o:p></p>
<p class="MsoNormal"><b><u>Example 2 Guidance:<o:p></o:p></u></b></p>
<p class="MsoNormal"><img border="0" width="460" height="339" style="width:4.7916in;height:3.5312in" id="Picture_x0020_2" src="cid:image004.jpg@01D7005E.F4C8B8C0" alt="cid:image006.jpg@01D70075.387FEB40"><o:p></o:p></p>
<p class="MsoNormal"><o:p> </o:p></p>
<p class="MsoNormal">Source: <a href="https://www.hhs.gov/sites/default/files/provider-relief-fund-general-distribution-faqs.pdf">
https://www.hhs.gov/sites/default/files/provider-relief-fund-general-distribution-faqs.pdf</a><o:p></o:p></p>
<p class="MsoNormal"><o:p> </o:p></p>
<div style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 1.0pt 0in">
<p class="MsoNormal"><span style="font-size:12.0pt"><o:p> </o:p></span></p>
</div>
<p class="MsoNormal"><span style="font-size:12.0pt">George D. Strudgeon, CPA, CGMA, CGFM, MBA<o:p></o:p></span></p>
<p class="MsoNormal"><span style="font-size:12.0pt">Audit Director – Compliance Assurance<o:p></o:p></span></p>
<p class="MsoNormal"><span style="font-size:12.0pt">804-362-7804 (direct) <span style="color:red">
(new as of 8/3/2020)<o:p></o:p></span></span></p>
<p class="MsoNormal"><span style="font-size:12.0pt">804-225-3350 (office main line)<o:p></o:p></span></p>
<p class="MsoNormal"><a href="mailto:George.Strudgeon@apa.virginia.gov"><span style="font-size:12.0pt;color:blue">George.Strudgeon@apa.virginia.gov</span></a><span style="font-size:12.0pt"><o:p></o:p></span></p>
<p class="MsoNormal"><a href="http://www.apa.virginia.gov/"><span style="font-size:12.0pt;color:blue">www.apa.virginia.gov</span></a><span style="font-size:12.0pt"><o:p></o:p></span></p>
<p class="MsoNormal"><o:p> </o:p></p>
</div>
</body>
</html>